A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors

European Journal of Pharmacology

Volumn 603, Issue 1-3, 2009, Pages 29-36

  Lotito, Luca ^a   Russo, Alessandra ^a   Bueno, Susana ^b   Chillemi, Giovanni ^b   Fogli, Maria Vittoria ^a   Capranico, Giovanni ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CASPUR   (Italy)

Author keywords

(S. cerevisiae); Antitumor activity; Camptothecin; DNA damage response; DNA topoisomerase I; Global transcriptional profiles

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MBP1P; TRANSCRIPTION FACTOR SWI4P; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CONTROLLED STUDY; FUNGAL GENE; GENE DELETION; GENETIC TRANSCRIPTION; MBP1 GENE; NONHUMAN; NUCLEIC ACID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SWI4 GENE; UPREGULATION; YEAST CELL;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CAMPTOTHECIN; CELL CYCLE; CELL PROLIFERATION; DNA REPLICATION; DNA TOPOISOMERASES, TYPE I; DOWN-REGULATION; GENE REGULATORY NETWORKS; GENES, FUNGAL; MUTATION; PROMOTER REGIONS, GENETIC; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 58249117998     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.002     Document Type: Article

References (41)

1. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet 25 (2000) 25-29
2. Begley T.J., Rosenbach A.S., Ideker T., and Samson L.D. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol. Cancer Res 1 (2002) 103-112
3. Birrell G.W., Brown J.A., Wu H.I., Giaever G., Chu A.M., Davis R.W., and Brown J.M. Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc. Natl. Acad. Sci. U. S. A 99 (2002) 8778-8783
4. Cagney G., Alvaro D., Reid R.J., Thorpe P.H., Rothstein R., and Krogan N.J. Functional genomics of the yeast DNA-damage response. Genome Biol 7 (2006) 233
5. Capranico G., Binaschi M., Borgnetto M.E., Zunino F., and Palumbo M. A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol. Sci 18 (1997) 323-329
6. Cavalieri D., Townsend J.P., and Hartl D.L. Manifold anomalies in gene expression in a vineyard isolate of Saccharomyces cerevisiae revealed by DNA microarray analysis. Proc. Natl. Acad. Sci. U. S. A 97 (2000) 12369-12374
7. Chabes A., and Stillman B. Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A 104 (2007) 1183-1188
8. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem 70 (2001) 369-413
9. Fry R.C., Begley T.J., and Samson L.D. Genome-wide responses to DNA-damaging agents. Annu. Rev. Microbiol 59 (2005) 357-377
10. Gasch A.P., Huang M., Metzner S., Botstein D., Elledge S.J., and Brown P.O. Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol. Biol. Cell 12 (2001) 2987-3003
11. Gasch A.P., Spellman P.T., Kao C.M., Carmel-Harel O., Eisen M.B., Storz G., Botstein D., and Brown P.O. Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell 11 (2000) 4241-4257
12. Harbison C.T., Gordon D.B., Lee T.I., Rinaldi N.J., Macisaac K.D., Danford T.W., Hannett N.M., Tagne J.B., Reynolds D.B., Yoo J., Jennings E.G., Zeitlinger J., Pokholok D.K., Kellis M., Rolfe P.A., Takusagawa K.T., Lander E.S., Gifford D.K., Fraenkel E., and Young R.A. Transcriptional regulatory code of a eukaryotic genome. Nature 431 (2004) 99-104
13. Ho Y., Mason S., Kobayashi R., Hoekstra M., and Andrews B. Role of the casein kinase I isoform, Hrr25, and the cell cycle-regulatory transcription factor, SBF, in the transcriptional response to DNA damage in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A 94 (1997) 581-586
14. Horak C.E., Luscombe N.M., Qian J., Bertone P., Piccirrillo S., Gerstein M., and Snyder M. Complex transcriptional circuitry at the G1/S transition in Saccharomyces cerevisiae. Genes Dev 16 (2002) 3017-3033
15. Houghton P.J., Stewart C.F., Thompson J., Santana V.M., Furman W.L., and Friedman H.S. Extending principles learned in model systems to clinical trials design. Oncology 12 (1998) 84-93 (Williston.Park)
16. Hughes T.R., Marton M.J., Jones A.R., Roberts C.J., Stoughton R., Armour C.D., Bennett H.A., Coffey E., Dai H., He Y.D., Kidd M.J., King A.M., Meyer M.R., Slade D., Lum P.Y., Stepaniants S.B., Shoemaker D.D., Gachotte D., Chakraburtty K., Simon J., Bard M., and Friend S.H. Functional discovery via a compendium of expression profiles. Cell 102 (2000) 109-126
17. Jelinsky S.A., Estep P., Church G.M., and Samson L.D. Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol. Cell Biol 20 (2000) 8157-8167
18. Li T.K., and Liu L.F. Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol 41 (2001) 53-77
19. Longhese M.P., Foiani M., Muzi-Falconi M., Lucchini G., and Plevani P. DNA damage checkpoint in budding yeast. EMBO J. 17 (1998) 5525-5528
20. Lotito L., Russo A., Chillemi G., Bueno S., Cavalieri D., and Capranico G. Global transcription regulation by DNA topoisomerase I in exponentially growing Saccharomyces cerevisiae cells: activation of telomere-proximal genes by TOP1 deletion. J. Mol. Biol 377 (2008) 311-322
21. Marin S., Mansilla S., Garcia-Reyero N., Rojas M., Portugal J., and Pina B. Promoter-specific inhibition of transcription by daunorubicin in Saccharomyces cerevisiae. Biochem. J. 368 (2002) 131-136
22. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6 (2006) 789-802
23. Reid R.J., Benedetti P., and Bjornsti M.A. Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. Biochim. Biophys. Acta 1400 (1998) 289-300
24. Reid R.J., Fiorani P., Sugawara M., and Bjornsti M.A. CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage. Proc. Natl. Acad. Sci. U. S. A 96 (1999) 11440-11445
25. Rojas M., Casado M., Portugal J., and Pina B. Selective inhibition of yeast regulons by daunorubicin: a transcriptome-wide analysis. BMC Genomics 9 (2008) 358
26. Rouse J. Esc4p, a new target of Mec1p (ATR), promotes resumption of DNA synthesis after DNA damage. EMBO J. 23 (2004) 1188-1197
27. Scaldaferro S., Tinelli S., Borgnetto M.E., Azzini A., and Capranico G. Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I. Chem. Biol 8 (2001) 871-881
28. Schaus S.E., Cavalieri D., and Myers A.G. Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure. Proc. Natl. Acad. Sci. U. S. A 98 (2001) 11075-11080
29. Spellman P.T., Sherlock G., Zhang M.Q., Iyer V.R., Anders K., Eisen M.B., Brown P.O., Botstein D., and Futcher B. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 9 (1998) 3273-3297
30. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin Jr. A.B., and Stewart L. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl. Acad. Sci. U. S. A 99 (2002) 15387-15392
31. Tong A.H., Lesage G., Bader G.D., Ding H., Xu H., Xin X., Young J., Berriz G.F., Brost R.L., Chang M., Chen Y., Cheng X., Chua G., Friesen H., Goldberg D.S., Haynes J., Humphries C., He G., Hussein S., Ke L., Krogan N., Li Z., Levinson J.N., Lu H., Menard P., Munyana C., Parsons A.B., Ryan O., Tonikian R., Roberts T., Sdicu A.M., Shapiro J., Sheikh B., Suter B., Wong S.L., Zhang L.V., Zhu H., Burd C.G., Munro S., Sander C., Rine J., Greenblatt J., Peter M., Bretscher A., Bell G., Roth F.P., Brown G.W., Andrews B., Bussey H., and Boone C. Global mapping of the yeast genetic interaction network. Science 303 (2004) 808-813
32. Vogelauer M., and Camilloni G. Site-specific in vivo cleavages by DNA topoisomerase I in the regulatory regions of the 35 S rRNA in Saccharomyces cerevisiae are transcription independent. J. Mol. Biol 293 (1999) 19-28
33. Wach A., Brachat A., Pohlmann R., and Philippsen P. New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10 (1994) 1793-1808
34. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol 3 (2002) 430-440
35. Wittenberg C., and Reed S.I. Cell cycle-dependent transcription in yeast: promoters, transcription factors, and transcriptomes. Oncogene 24 (2005) 2746-2755
36. Workman C.T., Mak H.C., McCuine S., Tagne J.B., Agarwal M., Ozier O., Begley T.J., Samson L.D., and Ideker T. A systems approach to mapping DNA damage response pathways. Science 312 (2006) 1054-1059
37. Yeang C.H., Mak H.C., McCuine S., Workman C., Jaakkola T., and Ideker T. Validation and refinement of gene-regulatory pathways on a network of physical interactions. Genome Biol 6 (2005) R62
38. Zaim J., Speina E., and Kierzek A.M. Identification of new genes regulated by the Crt1 transcription factor, an effector of the DNA damage checkpoint pathway in Saccharomyces cerevisiae. J Biol. Chem 280 (2005) 28-37
39. Zamboni W.C., Stewart C.F., Thompson J., Santana V.M., Cheshire P.J., Richmond L.B., Luo X., Poquette C., Houghton J.A., and Houghton P.J. Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J. Natl. Cancer Inst 90 (1998) 505-511
40. Zhao X., Chabes A., Domkin V., Thelander L., and Rothstein R. The ribonucleotide reductase inhibitor Sml1 is a new target of the Mec1/Rad53 kinase cascade during growth and in response to DNA damage. EMBO J 20 (2001) 3544-3553
41. Zhou Y., Gwadry F.G., Reinhold W.C., Miller L.D., Smith L.H., Scherf U., Liu E.T., Kohn K.W., Pommier Y., and Weinstein J.N. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res 62 (2002) 1688-1695